Amer Siddiq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amer Siddiq has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Aamir
Pathology Department, Islamic International Medical College, Riphah International University, Islamabad 46000, Pakistan
2 shared publications - Naveed Ahmed
Department of Industrial Engineering, College of Engineering, Al Yamamah University, Riyadh 11512, Saudi Arabia
2 shared publications Abdul Khaliq Naveed
Islamic International Medical College, Riphah International University
1 shared publication- Abdul Khaliq Naveed
Pathology Department, Islamic International Medical College, Riphah International University, Islamabad 46000, Pakistan
1 shared publication - Basit Zeshan
Department of Microbiology, Faculty of Life Sciences, University of Central Punjab, Lahore, Pakistan
1 shared publication - Chan Yean Yean
Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
1 shared publication
Latest Publications
- Open Access
Association of Pro-Inflammatory Cytokines with Vitamin D in Hashimoto’s Thyroid Autoimmune Disease
Background and objectives: Hashimoto’s thyroiditis is an important autoimmune thyroid condition. It is characterized by lymphocytic congestion of the thyroid gland followed by progressive deterioration and fibrous substitution of the thyroid in the parenchymal structure. This study has provided insight into the variations of blood pro-inflammatory cytokine levels in patients with Hashimoto’s disease and the key role of vitamin D levels among selected patients. Materials and Methods: A total of 144 participants including healthy controls and patients were studied in the current study in which 118 were female and 26 were male. The thyroid profile was evaluated in patients with Hashimoto’s thyroiditis and healthy controls. Results: The mean ± SD Free T4 in the patients was recorded as 14.0 ± 4.9 pg/mL, and TSH was 7.6 ± 2.5 IU/L, whereas the median ± IQR thyroglobulin antibodies (anti-TG) were 285 ± 142. Thyroid peroxidase antibodies (anti-TPO) were 160 ± 63.5, whereas in the healthy controls, the mean ± SD Free T4 was recorded as 17.2 ± 2.1 pg/mL, and TSH was 2.1 ± 1.4 IU/L, whereas the median ± IQR anti-TGs were 56.30 ± 46.06, and anti-TPO was 5.6 ± 5.12. The assessment of pro-inflammatory cytokines (pg/mL) and total Vitamin D levels (nmol/L) in patients with Hashimoto’s thyroiditis was recorded with values IL-1B 6.2 ± 0.8, IL-6 9.4 ± 0.4, IL-8 7.5 ± 0.5, IL-10 4.3 ± 0.1, IL-12 3.8 ± 0.5, TNF-α 7.6 ± 1.1, and total vitamin D 21.89 ± 3.5, whereas in healthy controls the mean ± SD IL-1B was 0.6 ± 0.1, IL-6 2.6 ± 0.5, IL-8 3.0 ± 1.2, IL-10 3.3 ± 1.3, IL-12 3.4 ± 0.4, TNF-α 1.4 ± 0.3 and total vitamin D was 42.26 ± 5.5. Conclusions: It was found that individuals with Hashimoto’s thyroiditis had raised serum levels of IL-1B, IL-6, IL-8, IL-10, IL-12, and TNF-α as compared to the healthy controls, whereas the total vitamin D levels were remarkably low as compared to health controls. Serum TSH, anti-TG, and anti-TPO levels were typically lower in controls and much higher in individuals with Hashimoto’s thyroiditis. The current study’s findings might aid in future studies and in the diagnosis and management of autoimmune thyroid disease.
Open AccessAssociation of Pro-Inflammatory Cytokines with Vitamin D in Hashimoto’s Thyroid Autoimmune Disease
Background and objectives: Hashimoto’s thyroiditis is an important autoimmune thyroid condition. It is characterized by lymphocytic congestion of the thyroid gland followed by progressive deterioration and fibrous substitution of the thyroid in the parenchymal structure. This study has provided insight into the variations of blood pro-inflammatory cytokine levels in patients with Hashimoto’s disease and the key role of vitamin D levels among selected patients. Materials and Methods: A total of 144 participants including healthy controls and patients were studied in the current study in which 118 were female and 26 were male. The thyroid profile was evaluated in patients with Hashimoto’s thyroiditis and healthy controls. Results: The mean ± SD Free T4 in the patients was recorded as 14.0 ± 4.9 pg/mL, and TSH was 7.6 ± 2.5 IU/L, whereas the median ± IQR thyroglobulin antibodies (anti-TG) were 285 ± 142. Thyroid peroxidase antibodies (anti-TPO) were 160 ± 63.5, whereas in the healthy controls, the mean ± SD Free T4 was recorded as 17.2 ± 2.1 pg/mL, and TSH was 2.1 ± 1.4 IU/L, whereas the median ± IQR anti-TGs were 56.30 ± 46.06, and anti-TPO was 5.6 ± 5.12. The assessment of pro-inflammatory cytokines (pg/mL) and total Vitamin D levels (nmol/L) in patients with Hashimoto’s thyroiditis was recorded with values IL-1B 6.2 ± 0.8, IL-6 9.4 ± 0.4, IL-8 7.5 ± 0.5, IL-10 4.3 ± 0.1, IL-12 3.8 ± 0.5, TNF-α 7.6 ± 1.1, and total vitamin D 21.89 ± 3.5, whereas in healthy controls the mean ± SD IL-1B was 0.6 ± 0.1, IL-6 2.6 ± 0.5, IL-8 3.0 ± 1.2, IL-10 3.3 ± 1.3, IL-12 3.4 ± 0.4, TNF-α 1.4 ± 0.3 and total vitamin D was 42.26 ± 5.5. Conclusions: It was found that individuals with Hashimoto’s thyroiditis had raised serum levels of IL-1B, IL-6, IL-8, IL-10, IL-12, and TNF-α as compared to the healthy controls, whereas the total vitamin D levels were remarkably low as compared to health controls. Serum TSH, anti-TG, and anti-TPO levels were typically lower in controls and much higher in individuals with Hashimoto’s thyroiditis. The current study’s findings might aid in future studies and in the diagnosis and management of autoimmune thyroid disease.
- Open Access
- 3 April 2023
- Published by Springer Nature in Research Square
Vitamin D Receptor Gene polymorphisms and Genetic susceptibility to Hashimoto’s Thyroiditis
Background The severity and complexity of autoimmune disorders is dependent on the genetic capability of individuals. Genetic studies have revealed association between polymorphisms of Vitamin D Receptor gene and individuals’ predisposition to autoimmune diseases. Therefore, this study aimed to develop relationship between vitamin D receptor gene polymorphisms and hypothyroidism. Materials and Methods A total of 144 individuals were studies, including 72 patients presenting with symptoms of Hashimoto’s disease. The amplicon sequencing was performed on samples bearing M13 tail tags. Statistical analysis was carried out using SPSS software to establish correlations of genotypes and alleles among control and diseased individuals. Results The mean concentrations of vitamin D were observed to be critically low in patients with Hashimoto’s thyroiditis. Of the four SNPs studied, only rs7975232 was found to be significantly related with disease progression. Other three rs1544410, rs731236 and rs2228570 did not show significant correlation in the individuals studied. Conclusion Altered VDR expressions because of various VDR polymorphisms have been shown to exhibit differently among various races and ethnic groups. Furthermore, these VDR polymorphisms also vary among populations in different environmental and genetic predispositions. This study suggests the homozygous CC genotype at rs7975232 to be more as a risk factor for development of Hashimoto’s disease in the population studied.
- 3 April 2023
- Published by Springer Nature in Research Square
Open AccessVitamin D Receptor Gene polymorphisms and Genetic susceptibility to Hashimoto’s Thyroiditis
Background The severity and complexity of autoimmune disorders is dependent on the genetic capability of individuals. Genetic studies have revealed association between polymorphisms of Vitamin D Receptor gene and individuals’ predisposition to autoimmune diseases. Therefore, this study aimed to develop relationship between vitamin D receptor gene polymorphisms and hypothyroidism. Materials and Methods A total of 144 individuals were studies, including 72 patients presenting with symptoms of Hashimoto’s disease. The amplicon sequencing was performed on samples bearing M13 tail tags. Statistical analysis was carried out using SPSS software to establish correlations of genotypes and alleles among control and diseased individuals. Results The mean concentrations of vitamin D were observed to be critically low in patients with Hashimoto’s thyroiditis. Of the four SNPs studied, only rs7975232 was found to be significantly related with disease progression. Other three rs1544410, rs731236 and rs2228570 did not show significant correlation in the individuals studied. Conclusion Altered VDR expressions because of various VDR polymorphisms have been shown to exhibit differently among various races and ethnic groups. Furthermore, these VDR polymorphisms also vary among populations in different environmental and genetic predispositions. This study suggests the homozygous CC genotype at rs7975232 to be more as a risk factor for development of Hashimoto’s disease in the population studied.
- 1 February 2022
- Published by Elsevier in Analytical Biochemistry
- Vol. 638, 114496
A novel method development and validation for determination of 2,4,6-Trinitrotoluene and its metabolites on LC-MS/MS
- 1 February 2022
- Published by Elsevier in Analytical Biochemistry
- Vol. 638, 114496
A novel method development and validation for determination of 2,4,6-Trinitrotoluene and its metabolites on LC-MS/MS
- Open Access
- 29 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 11 (1) , 35
The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance
Antimicrobial resistance (AMR) is a global health issue that plays a significant role in morbidity and mortality, especially in immunocompromised patients. It also becomes a serious threat to the successful treatment of many bacterial infections. The widespread and irrelevant use of antibiotics in hospitals and local clinics is the leading cause of AMR. Under this scenario, the study was conducted in a tertiary care hospital in Lahore, Pakistan, from 2 August 2021 to 31 October 2021 to discover the prevalence of bacterial infections and AMR rates in COVID-19 patients admitted in surgical intensive care units (SICUs). Clinical samples were collected from the patients and we proceeded to identify bacterial isolates, followed by antibiotic susceptibility testing (AST) using the Kirby Bauer disk diffusion method and minimum inhibitory concentration (MIC). The data of other comorbidities were also collected from the patient’s medical record. The current study showed that the most common pathogens were E. coli (32%) and Klebsiella pneumoniae (17%). Most E. coli were resistant to ciprofloxacin (16.8%) and ampicillin (19.8%). Klebsiella pneumoniae were more resistant to ampicillin (13.3%) and amoxycillin (12.0%). The most common comorbidity was chronic kidney disease (CKD) and urinary tract infections (UTIs). Around 17 different types of antibiotic, the carbapenem, fluoroquinolones, aminoglycoside, and quinolones, were highly prevalent in ICU patients. The current study provides valuable data on the clinical implication of antibiotics consumed by COVID-19 patients in SICUs and the AMR rates, especially with different comorbidities.
- 29 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 11 (1) , 35
Open AccessThe Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance
Antimicrobial resistance (AMR) is a global health issue that plays a significant role in morbidity and mortality, especially in immunocompromised patients. It also becomes a serious threat to the successful treatment of many bacterial infections. The widespread and irrelevant use of antibiotics in hospitals and local clinics is the leading cause of AMR. Under this scenario, the study was conducted in a tertiary care hospital in Lahore, Pakistan, from 2 August 2021 to 31 October 2021 to discover the prevalence of bacterial infections and AMR rates in COVID-19 patients admitted in surgical intensive care units (SICUs). Clinical samples were collected from the patients and we proceeded to identify bacterial isolates, followed by antibiotic susceptibility testing (AST) using the Kirby Bauer disk diffusion method and minimum inhibitory concentration (MIC). The data of other comorbidities were also collected from the patient’s medical record. The current study showed that the most common pathogens were E. coli (32%) and Klebsiella pneumoniae (17%). Most E. coli were resistant to ciprofloxacin (16.8%) and ampicillin (19.8%). Klebsiella pneumoniae were more resistant to ampicillin (13.3%) and amoxycillin (12.0%). The most common comorbidity was chronic kidney disease (CKD) and urinary tract infections (UTIs). Around 17 different types of antibiotic, the carbapenem, fluoroquinolones, aminoglycoside, and quinolones, were highly prevalent in ICU patients. The current study provides valuable data on the clinical implication of antibiotics consumed by COVID-19 patients in SICUs and the AMR rates, especially with different comorbidities.